These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2736527)

  • 1. Modulation of prostaglandin biosynthesis in hypoxic murine mammary adenocarcinoma cells by misonidazole.
    Shalinsky DR; McNamara DB; Agrawal KC
    Cancer Res; 1989 Jul; 49(14):3853-6. PubMed ID: 2736527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of hypoxic radiosensitizer after mild hyperthermia in C3H mammary carcinoma.
    Ohizumi Y; Murayama C; Maezawa H; Mori T
    Tokai J Exp Clin Med; 1984 Oct; 9(4):331-7. PubMed ID: 6537042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of artificial lung metastases by misonidazole.
    Rockwell S; Nierenburg M; Irvin CG
    Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1395-8. PubMed ID: 6469763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polarographic measurement of misonidazole in mouse mammary tumors.
    Ohizumi Y; Maezawa H; Murayama C; Mori T
    Tokai J Exp Clin Med; 1984 Aug; 9(3):199-206. PubMed ID: 6537667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxygen dependence of binding of misonidazole to rodent and human tumors in vitro.
    Franko AJ; Koch CJ; Garrecht BM; Sharplin J; Hughes D
    Cancer Res; 1987 Oct; 47(20):5367-76. PubMed ID: 3652041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth inhibition and eicosanoid metabolism in the R3230AC mammary adenocarcinoma by interferon.
    Karmali RA; Schellekens H; Lefevre F; Marsh J; Fuchs C; Krim M
    Cancer Treat Rep; 1986 Mar; 70(3):397-400. PubMed ID: 2420445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of misonidazole on formation of thymine damage by gamma rays.
    Remsen JF
    Radiat Res; 1985 Feb; 101(2):306-11. PubMed ID: 3975359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioreductive metabolism of AF-2[2-(2-furyl)-3-(5-nitro-2-furyl)acrylamide] combined with 2-nitroimidazoles. Implications for use as hypoxic cell markers.
    Koch CJ; Giandomenico AR; Iyengar CW
    Biochem Pharmacol; 1993 Sep; 46(6):1029-36. PubMed ID: 8216345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modification of the metabolism and cytotoxicity of bioreductive alkylating agents by dicoumarol in aerobic and hypoxic murine tumor cells.
    Keyes SR; Rockwell S; Sartorelli AC
    Cancer Res; 1989 Jun; 49(12):3310-3. PubMed ID: 2470504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitroimidazole adducts as markers for tissue hypoxia: mechanistic studies in aerobic normal tissues and tumour cells.
    Parliament MB; Wiebe LI; Franko AJ
    Br J Cancer; 1992 Dec; 66(6):1103-8. PubMed ID: 1280990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response of aerobic and hypoxic cells in a solid tumor to adriamycin and cyclophosphamide and interaction of the drugs with radiation.
    Tannock I
    Cancer Res; 1982 Dec; 42(12):4921-6. PubMed ID: 7139596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo radiosensitizing effects of 2-nitroimidazole derivatives with sugar component.
    Murayama C; Tanaka N; Miyamoto Y; Sakaguchi M; Mori T
    Strahlenther Onkol; 1987 Jun; 163(6):385-90. PubMed ID: 3603366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of acidic pH on radiosensitization of FSaIIC cells in vitro by misonidazole, etanidazole, or cis-diamminedichloroplatinum (II).
    Herman TS; Teicher BA; Pfeffer MR; Khandekar V; Chapnick RM; Kalick GS; Rabow A
    Radiat Res; 1990 Oct; 124(1):28-33. PubMed ID: 2146699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of prolonged exposure of HELA S3 cells to low concentrations of misonidazole.
    Ohizumi Y; Shibata C; Maezawa H; Ushiro S; Mori T
    Gan; 1981 Oct; 72(5):717-22. PubMed ID: 7327372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperthermia enhances the cytotoxicity against hypoxic cells of RP-170, a new 2-nitroimidazole nucleoside hypoxic cell sensitizer.
    Emi Y; Maehara Y; Kusumoto T; Baba H; Sakaguchi M; Sugimachi K
    Oncology; 1995; 52(1):55-9. PubMed ID: 7800343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of hyperthermia on the activity of 1-[(4'-hydroxy-2'-butenoxy)methyl]-2-nitroimidazole, which is cytotoxic to hypoxic cells.
    Kusumoto T; Maehara Y; Emi Y; Sakaguchi Y; Baba H; Sakaguchi M; Sugimachi K
    Cancer Chemother Pharmacol; 1993; 31(6):455-8. PubMed ID: 8453684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of the metabolism-induced binding of misonidazole to hypoxic mammalian cells.
    Chapman JD; Baer K; Lee J
    Cancer Res; 1983 Apr; 43(4):1523-8. PubMed ID: 6831401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of hypoxic cell radio-sensitizers in terms of radio-sensitizing and repair-inhibiting potential. Dependency on p53 status of tumor cells and the effects on intratumor quiescent cells.
    Masunaga S; Uto Y; Nagasawa H; Hori H; Nagata K; Suzuki M; Kinashi Y; Ono K
    Anticancer Res; 2006; 26(2A):1261-70. PubMed ID: 16619533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoxic fraction and binding of misonidazole in EMT6/Ed multicellular tumor spheroids.
    Franko AJ
    Radiat Res; 1985 Jul; 103(1):89-97. PubMed ID: 4070561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth inhibition and prostaglandin metabolism in the R3230AC mammary adenocarcinoma by reduced glutathione.
    Karmali RA
    Cancer Biochem Biophys; 1984 Jun; 7(2):147-54. PubMed ID: 6432306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.